JPH07501339A - 創傷治癒組成物,その調製方法と使用 - Google Patents
創傷治癒組成物,その調製方法と使用Info
- Publication number
- JPH07501339A JPH07501339A JP51009793A JP51009793A JPH07501339A JP H07501339 A JPH07501339 A JP H07501339A JP 51009793 A JP51009793 A JP 51009793A JP 51009793 A JP51009793 A JP 51009793A JP H07501339 A JPH07501339 A JP H07501339A
- Authority
- JP
- Japan
- Prior art keywords
- composition
- fatty acids
- acid
- wound healing
- pyruvate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
- A61L17/005—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters containing a biologically active substance, e.g. a medicament or a biocide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/21—Acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/22—Lipids, fatty acids, e.g. prostaglandins, oils, fats, waxes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/428—Vitamins, e.g. tocopherol, riboflavin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Materials Engineering (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Transplantation (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (25)
- 1.(a)ピルビン酸、医薬品として許容できるピルビン酸の塩、及びその混合 物から構成される群から選択されるピルビン酸類:(b)抗酸化剤;及び (c)飽和脂肪酸と不飽和脂肪酸の混合物、但し、脂肪酸は哺乳動物の細胞膜の 修復と哺乳動物の細胞の蘇生の為に必要とされるような脂肪酸である;以上の( a)〜(c)から成る治療用の創傷治癒組成物。
- 2.哺乳動物の細胞が表皮のケラチン細胞である請求の範囲第1項記載の組成物 。
- 3.ピルビン酸類が、ピルビン酸、ピルビン酸ナトリウム、ピルビン酸カリウム 、ピルビン酸マグネシウム、ピルビン酸カルシウム、ピルビン酸亜鉛、ピルビン 酸マンガン、及びその混合物から溝成される群から選ばれる請求の範囲第1項記 載の組成物。
- 4.ピルビン酸類がピルビン酸ナトリウムである請求の範囲第3項記載の組成物 。
- 5.抗酸化剤が、レチノール、3,4−ジデヒドロレチノール、α−カロチン、 β−カロチン、γ−カロチン、δ−カロチン、アスコルビン酸、α−トコフェロ ール、β−トコフェロール、γ−トコフェロール、δ−トコフェロール、及びそ の混合物から構成される群から選ばれる請求の範囲第1項記載の組成物。
- 6.抗酸化剤がα−トコフェロールである請求の範囲第5項記載の組成物。
- 7.飽和脂肪酸と不飽和脂肪酸の混合物に動物脂肪と植物脂肪及びワックスが包 含される請求の範囲第1項記載の組成物。
- 8.飽和脂肪酸と不飽和脂肪酸の混合物にヒト脂肪、若鶏の脂肪、牛の脂肪、羊 の脂肪、馬の脂肪、豚の脂肪、及び鯨の脂肪が包含される請求の範囲第7項記載 の組成物。
- 9.飽和脂肪酸と不飽和脂肪酸の混合物に、ラウリン酸、ミリスチン酸、ミリス トール酸、ペンタデカン酸、パルミチン酸、パルミトール酸、マルガリン酸、マ ルガロール酸、ステアリン酸、オレイン酸、リノール酸、リノレン酸、アラキジ ン酸、及びガドレン酸が包含される請求の範囲第8項記載の組成物。
- 10.ピルビン酸類が治療薬組成物の重量を基準として、その約10%から約5 0%の量で治療薬組成物中に存在する請求の範囲第1項記載の組成物。
- 11.抗酸化剤が治療薬組成物の重重を基準としてその約10%から約50%の 量で治療薬組成物中に存在する請求の範囲第1項記載の組成物。
- 12.飽和脂肪酸と不飽和脂肪酸の混合物が治療薬組成物の重量を基準として、 その約10%から約50%の量で治療薬組成物中に存在する請求の範囲第1項記 載の組成物。
- 13.下記の成分: (a)ピルビン酸、医薬品として許容できるピルビン酸の塩、及びその混合物か ら構成される群から選択されるピルビン酸類:(b)抗酸化剤;及び (c)飽和脂肪酸と不飽和脂肪酸の混合物、但し、脂肪酸は哺乳動物の細胞膜の 修復と哺乳動物の細胞の蘇生の為に必要とされるような脂肪酸である;を混和す る工程を含む治療薬の創傷治癒組成物の調製方法。
- 14. (A)(a)ピルビン酸、医薬品として許容できるピルビン酸の塩、及びその混 合物から構成される群から選択されるピルビン酸類;(b)抗酸化剤;及び (c)飽和脂肪酸と不飽和脂肪酸の混合物、但し、脂肪酸は哺乳動物の細胞膜の 修復と哺乳動物の細胞の蘇生の為に必要とされるような脂肪酸である;以上の( a)〜(c)から成る治療薬の創傷治癒組成物を用意し;(B)創傷治癒組成物 を傷と接触させる;以上の(A)と(B)の段階から成る哺乳動物の傷の治癒方 法。
- 15. (A)(a)ピルビン酸、医薬品として許容できるピルビン酸の塩、及びその混 合物から構成される群から選択されるピルビン酸類;(b)抗酸化剤;及び (c)飽和脂肪酸と不飽和脂肪酸の混合物、但し、脂肪酸は哺乳動物の細胞膜の 修復と哺乳動物の細胞の蘇生の為に必要とされるような脂肪酸である;以上の( a)〜(c)から成る治療薬の創傷治癒組成物;(B)傷を治療するのに有用な 医薬; 以上の(A)と(B)とを含む効果の高められた創傷治癒組成物。
- 16.傷を治療するのに有用な医薬が、抗炎症剤、呼吸パースト抑制剤、プロス タグランジン合成の抑制剤、抗菌剤、抗微生物剤(抗生物質)、防腐剤、麻酔剤 、細胞の栄養培地、火傷(やけど)防止剤、日焼け防止剤、面皰(にきび)軽減 調剤、昆虫の噛み傷と刺し傷用の医薬、傷口の洗浄剤、傷の手当薬、傷痕減少剤 、免疫刺激剤、及びその混合物から構成される群から選ばれる請求の範囲第15 項記載の効果の高められた創傷治癒組成物。
- 17. (A)(a)ピルビン酸、医薬品として許容できるピルビン酸の塩、及びその混 合物から構成される群から選択されるピルビン酸類;(b)抗酸化剤;及び (c)飽和脂肪酸と不飽和脂肪酸の混合物、但し、脂肪酸は哺乳動物の細胞膜の 修復と哺乳動物の細胞の蘇生の為に必要とされるような脂肪酸である;以上の( a)〜(c)を含む治療用の創傷治癒組成物を準備し:(B)傷の治療に有用な 医薬限準備し;そして(C)段階(A)からの創傷治癒組成物を段階(B)から の傷の治療に有用な医薬と混和して効果の高められた創傷治癒組成物を調製する ;以上の(A)〜(C)の工程を含む効果の高められた創傷治癒組成物の調製方 法。
- 18. (A)(a)ピルビン酸、医薬品として許容できるピルビン酸の塩、及びその混 合物から構成される群から選択されるピルビン酸類;(b)抗酸化剤:及び (c)飽和脂肪酸と不飽和脂肪酸の混合物、但し、脂肪酸は哺乳動物の細胞膜の 修復と哺乳動物の細胞の蘇生の為に必要とされるような脂肪酸である;以上の( a)〜(c)を含む治療用の創傷治癒組成物を準備し:(B)傷の治療に有用な 医薬を準備し;そして(C)段階(A)からの創傷治癒組成物と段階(B)から の傷の治療に有用な医薬を同時に傷と接触させる: 以上の(A)〜(C)の段階から哺乳動物の傷を治応する方法。
- 19.(a)ピルビン酸、医薬品として許容できるピルビン酸の塩、及びその混 合物から構成される群から選択されるピルビン酸類;(b)抗酸化剤;及び (c)飽和脂肪酸と不飽和脂肪酸の混合物、但し、脂肪酸は哺乳動物の細胞膜の 修復と哺乳動物の細胞の蘇生の為に必要とされるような脂肪酸である;以上の( a)〜(c)を含む創傷治癒組成物の治療に効果的な量と医薬品として許容され るキャリヤーとを含む創傷治癒用の医薬組成物。
- 20.医薬品として許容できるキャリヤーが薬剤学の用品である請求の範囲第1 9項記載の医薬組成物。
- 21.医薬品として許容できるキャリヤーが生体接着剤である請求の範囲第19 項記載の医薬組成物。
- 22.医薬品として許容できるキャリヤーが局所適用のビヒクルである請求の範 囲第19項記載の医薬組成物。
- 23.局所適用のビヒクルが吸収・吸着性のビヒクルである請求の範囲第22項 記載の調合薬組成物。
- 24.創傷治癒組成物が医薬組成物の重量を基準として、その約0.1%から約 10%の量で医薬組成物中に存在する請求の範囲第19項記載の医薬組成物。
- 25. (A)(a)ピルビン酸、医薬品として許容できるピルビン酸の塩、及びその混 合物から構成される群から選択されるピルビン酸類;(b)抗酸化剤;及び (c)飽和脂肪酸と不飽和脂肪酸の混合物、但し、脂肪酸は哺乳動物の細胞膜の 修復と哺乳動物の細胞の蘇生の為に必要とされるような脂肪酸である;以上の( a)〜(c)から成る創傷治癒組成物の治療に効果的な量を準備し;(B)医薬 品として許容できるキャリヤーを準備し;そして(C)段階(A)からの創傷治 癒組成物と段階(B)からの医薬品として許容できるキャリヤーを混和して医薬 組成物を形成する;以上の(A)〜(C)の工程を含む創傷治癒用の調合薬組成 物の調製方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US79839291A | 1991-11-26 | 1991-11-26 | |
US798,392 | 1991-11-26 | ||
PCT/US1992/008787 WO1993010776A1 (en) | 1991-11-26 | 1992-10-15 | Wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH07501339A true JPH07501339A (ja) | 1995-02-09 |
JP3506701B2 JP3506701B2 (ja) | 2004-03-15 |
Family
ID=25173285
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51009793A Expired - Lifetime JP3506701B2 (ja) | 1991-11-26 | 1992-10-15 | 創傷治癒組成物,その調製方法と使用 |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0614359A1 (ja) |
JP (1) | JP3506701B2 (ja) |
CA (1) | CA2123678A1 (ja) |
MX (1) | MX9206792A (ja) |
NZ (1) | NZ245275A (ja) |
WO (1) | WO1993010776A1 (ja) |
ZA (1) | ZA929155B (ja) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002514574A (ja) * | 1998-05-12 | 2002-05-21 | エヌ・ヴイ・ヌートリシア | 圧迫性潰瘍の治療のための栄養組成物 |
JP2002537070A (ja) * | 1999-02-26 | 2002-11-05 | ワーナー−ランバート・カンパニー | 生体接着性抗菌性創傷治癒用組成物 |
JP2003505156A (ja) * | 1999-07-22 | 2003-02-12 | デロイヤル インダストリーズ インコーポレィテッド | 傷の治療を向上させる方法及び組成物 |
JP2008530115A (ja) * | 2005-02-11 | 2008-08-07 | ノース セル ファーマシューティカル インコーポレイテッド | 過酸化亜硝酸の過剰発現によって起きる哺乳動物の疾患および傷害の治療のための方法および組成物 |
JP2016088885A (ja) * | 2014-11-04 | 2016-05-23 | 株式会社シー・アクト | 脂肪酸混合物 |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU713829B2 (en) * | 1991-03-01 | 1999-12-09 | Warner-Lambert Company Llc | Immunostimulating wound healing compositions and methods for preparing and using same |
US5663208A (en) * | 1991-03-01 | 1997-09-02 | Warner-Lambert Company | Antifungal wound healing compositions and methods for preparing and using same |
US5641814A (en) * | 1991-03-01 | 1997-06-24 | Warner-Lambert Company | Antikeratolytic-wound healing compositions and methods for preparing and using same |
US5674912A (en) * | 1991-03-01 | 1997-10-07 | Warner-Lambert Company | Sunscreen-wound healing compositions and methods for preparing and using same |
US5856364A (en) * | 1991-03-01 | 1999-01-05 | Warner Lambert Company | Therapeutic antiviral-wound healing compositions and methods for preparing and using same |
US5602183A (en) * | 1991-03-01 | 1997-02-11 | Warner-Lambert Company | Dermatological wound healing compositions and methods for preparing and using same |
AU711789B2 (en) * | 1991-03-01 | 1999-10-21 | Warner-Lambert Company Llc | Antibacterial-wound healing compositions and methods for preparing and using same |
US5646190A (en) * | 1991-03-01 | 1997-07-08 | Warner-Lambert Company | Acne treating-wound healing compositions and methods for preparing and using same |
US5658957A (en) * | 1991-03-01 | 1997-08-19 | Warner Lambert Company | Immunostimulating wound healing compositions and method for preparing and using same |
US5658956A (en) * | 1991-03-01 | 1997-08-19 | Warner-Lambert Company | Bioadhesive-wound healing compositions and methods for preparing and using same |
US5863938A (en) * | 1991-03-01 | 1999-01-26 | Warner Lambert Company | Antibacterial-wound healing compositions and methods for preparing and using same |
US5614561A (en) * | 1991-03-01 | 1997-03-25 | Warner-Lambert Company | Antihistamine-wound healing compositions and methods for preparing and using same |
US5648380A (en) * | 1991-03-01 | 1997-07-15 | Warner-Lambert Company | Anti-inflammatory wound healing compositions and methods for preparing and using same |
JPH07505145A (ja) * | 1992-02-25 | 1995-06-08 | ワーナー−ランバート・コンパニー | 細胞保護組成物およびその製法および使用法 |
JP3940166B2 (ja) * | 1994-09-30 | 2007-07-04 | エバレデイ バツテリ カンパニー インコーポレーテツド | 創傷を治癒する組成物を含むレザーカートリッジ |
DE69432149T2 (de) * | 1994-11-11 | 2003-07-24 | Unilever Nv | Orale Zubereitungen |
DE4444237C2 (de) * | 1994-12-13 | 2000-08-24 | Beiersdorf Ag | Verwendung von Wirkstoffkombinationen zur Bekämpfung durch Propionibacterium acnes hervorgerufener unreiner Haut sowie leichter Formen der Akne |
CN1093756C (zh) * | 1996-01-31 | 2002-11-06 | 尤尼利弗公司 | 口腔用制剂 |
AU6486096A (en) * | 1996-05-08 | 1997-11-26 | Government Of The United States Of America As Represented By The Secretary Of The Army | Pharmaceutical compositions containing alpha-keto carboxylates |
FR2769535B1 (fr) | 1997-10-15 | 1999-12-31 | Bic Soc | Bande antifriction extrudee pour tete de rasage et tete de rasage comportant une telle bande |
WO2007108438A1 (ja) * | 2006-03-20 | 2007-09-27 | Rohto Pharmaceutical Co., Ltd. | グルタチオンの産生を促進するための外用組成物及び方法 |
EP3067051A1 (en) * | 2011-02-17 | 2016-09-14 | CHD Bioscience, Inc. | Compositions comprising peroxy alpha-ketocarboxylic acid and methods for producing and using the same |
CN116440112A (zh) * | 2014-01-24 | 2023-07-18 | 国立大学法人京都大学 | 含有稀有脂肪酸的抗炎剂 |
US20150374878A1 (en) * | 2014-06-27 | 2015-12-31 | Akeso Biomedical, Inc. | Angiogenic devices for wound care |
WO2023141574A1 (en) * | 2022-01-21 | 2023-07-27 | Beta Biofuel Solutions, Llc | Topical therapeutic |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54159537A (en) * | 1978-06-07 | 1979-12-17 | Ohbayashigumi Ltd | Fan-driven generator |
JPS5882080A (ja) * | 1981-09-23 | 1983-05-17 | グイリエ−ルモ・ド・サタライン・フエルナンドス | 風のエネルギを工業的に利用して電気エネルギに変換するための装置 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3719097C1 (de) * | 1987-06-06 | 1988-06-09 | Fratzer Uwe | Arzneimittel,enthaltend Eicosapentaensaeure und Docosahexaensaeure als ungesaettigte Fettsaeuren sowie Vitamin E |
GB8813766D0 (en) * | 1988-06-10 | 1988-07-13 | Efamol Holdings | Essential fatty acid compositions |
-
1992
- 1992-10-15 EP EP92921727A patent/EP0614359A1/en not_active Withdrawn
- 1992-10-15 WO PCT/US1992/008787 patent/WO1993010776A1/en not_active Application Discontinuation
- 1992-10-15 JP JP51009793A patent/JP3506701B2/ja not_active Expired - Lifetime
- 1992-10-15 CA CA002123678A patent/CA2123678A1/en not_active Abandoned
- 1992-11-25 ZA ZA929155A patent/ZA929155B/xx unknown
- 1992-11-25 MX MX9206792A patent/MX9206792A/es unknown
- 1992-11-26 NZ NZ245275A patent/NZ245275A/en not_active IP Right Cessation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54159537A (en) * | 1978-06-07 | 1979-12-17 | Ohbayashigumi Ltd | Fan-driven generator |
JPS5882080A (ja) * | 1981-09-23 | 1983-05-17 | グイリエ−ルモ・ド・サタライン・フエルナンドス | 風のエネルギを工業的に利用して電気エネルギに変換するための装置 |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002514574A (ja) * | 1998-05-12 | 2002-05-21 | エヌ・ヴイ・ヌートリシア | 圧迫性潰瘍の治療のための栄養組成物 |
JP2002537070A (ja) * | 1999-02-26 | 2002-11-05 | ワーナー−ランバート・カンパニー | 生体接着性抗菌性創傷治癒用組成物 |
JP2003505156A (ja) * | 1999-07-22 | 2003-02-12 | デロイヤル インダストリーズ インコーポレィテッド | 傷の治療を向上させる方法及び組成物 |
JP2008530115A (ja) * | 2005-02-11 | 2008-08-07 | ノース セル ファーマシューティカル インコーポレイテッド | 過酸化亜硝酸の過剰発現によって起きる哺乳動物の疾患および傷害の治療のための方法および組成物 |
JP2016088885A (ja) * | 2014-11-04 | 2016-05-23 | 株式会社シー・アクト | 脂肪酸混合物 |
Also Published As
Publication number | Publication date |
---|---|
MX9206792A (es) | 1993-05-01 |
ZA929155B (en) | 1993-05-25 |
EP0614359A1 (en) | 1994-09-14 |
WO1993010776A1 (en) | 1993-06-10 |
AU674131B2 (en) | 1996-12-12 |
JP3506701B2 (ja) | 2004-03-15 |
AU2808992A (en) | 1993-06-28 |
CA2123678A1 (en) | 1993-06-10 |
NZ245275A (en) | 1995-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH07501339A (ja) | 創傷治癒組成物,その調製方法と使用 | |
EP0792163B1 (en) | Acne treating-wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids | |
US5648380A (en) | Anti-inflammatory wound healing compositions and methods for preparing and using same | |
US5602183A (en) | Dermatological wound healing compositions and methods for preparing and using same | |
US5674912A (en) | Sunscreen-wound healing compositions and methods for preparing and using same | |
US5663208A (en) | Antifungal wound healing compositions and methods for preparing and using same | |
CA2218619C (en) | Antibacterial-wound healing compositions and methods for preparing and using same | |
US5641814A (en) | Antikeratolytic-wound healing compositions and methods for preparing and using same | |
US5633285A (en) | Cytoprotective wound healing compositions and methods for preparing and using same | |
WO1996003149A9 (en) | Antifungal-wound healing compositions and methods for preparing and using same | |
US5692302A (en) | Razor cartridges comprising wound healing compositions and methods for preparing and using same | |
US7122578B2 (en) | Method and composition for treating mammalian diseases and injuries which cause pain, erythema, swelling, crusting, ischemia scarring and excess white blood cell infiltration | |
AU674131C (en) | Wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids | |
AU701301B2 (en) | Antikeratolytic-wound healing compositions and methods for preparing and using same | |
AU701454B2 (en) | Anti-inflammatory wound healing compositions and methods for preparing and using same | |
AU701179B2 (en) | Antifungal-wound healing compositions and methods for preparing and using same | |
EP0783398B1 (en) | Razor cartridges comprising wound healing compositions | |
AU711789B2 (en) | Antibacterial-wound healing compositions and methods for preparing and using same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20031217 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
S533 | Written request for registration of change of name |
Free format text: JAPANESE INTERMEDIATE CODE: R313533 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20071226 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20081226 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20091226 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101226 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20101226 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111226 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20111226 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121226 Year of fee payment: 9 |
|
EXPY | Cancellation because of completion of term | ||
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20121226 Year of fee payment: 9 |